NRx Pharmaceuticals (NRXP) News Today → Bible Shocker: Have You Seen Elon Musk’s Miracle? (From InvestorPlace) (Ad) Free nrxp Stock Alerts $3.54 +0.02 (+0.57%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19 at 10:58 AM | msn.comNRx Pharmaceuticals Holds Promise for Investors and Patients AlikeMay 15, 2024 | msn.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q1 2024 Earnings Call TranscriptMay 15, 2024 | finanznachrichten.deNRx Pharmaceuticals, Inc.: NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 15, 2024 | finance.yahoo.comNRX Pharmaceuticals Inc (NRXP) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...May 14, 2024 | investorplace.comNRXP Stock Earnings: NRX Pharmaceuticals Misses EPS for Q1 2024May 14, 2024 | prnewswire.comNRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 13, 2024 | msn.comNRx Pharmaceuticals to Unveil First Quarter Financial Results and Corporate UpdateMay 13, 2024 | msn.comNRx Pharmaceuticals Makes Significant Stride with New Depression Drug, Aims for Accelerated FDA ApprovalMay 12, 2024 | americanbankingnews.comNRx Pharmaceuticals (NRXP) to Release Earnings on TuesdayMay 8, 2024 | markets.businessinsider.comNRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces Breakthroughs in Bi-Annual Milestone UpdateMay 8, 2024 | prnewswire.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024May 7, 2024 | prnewswire.comNRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Report First Quarter 2024 Financial Results on May 14, 2024May 6, 2024 | marketwatch.comNRx Pharmaceuticals Shares Rise 38% After Positive Drug Trial DataMay 6, 2024 | markets.businessinsider.comNRx Pharmaceuticals Plans To Seek Accelerated Approval Of NRX-101 - Quick FactsMay 6, 2024 | prnewswire.comNRx Pharmaceuticals (Nasdaq:NRXP) Announces Final Clinical Trial Results: Superior Safety Combined with Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar DepressionApril 30, 2024 | prnewswire.comNRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar DepressionApril 18, 2024 | investorplace.comWhy Is NRX Pharmaceuticals (NRXP) Stock Down 29% Today?April 18, 2024 | finance.yahoo.comNRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common StockApril 18, 2024 | finance.yahoo.comNRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price RequirementApril 18, 2024 | prnewswire.comNRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price RequirementApril 18, 2024 | prnewswire.comNRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common StockApril 17, 2024 | markets.businessinsider.comNRx Pharmaceuticals: New Data Demonstrates No Impact Of NRX-101 On Gut Or Vaginal FloraApril 17, 2024 | finance.yahoo.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infectionsApril 15, 2024 | prnewswire.comNRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)April 14, 2024 | msn.comNRx Pharmaceuticals Advances in Breakthrough Bipolar Depression TreatmentApril 10, 2024 | marketbeat.comShort Interest in NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Declines By 88.6%NRx Pharmaceuticals, Inc. (NASDAQ:NRXP - Get Free Report) saw a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 424,500 shares, a decrease of 88.6% from the March 15th total of 3,710,000 shares. Based on an average daily trading volume, of 159,600 shares, the days-to-cover ratio is presently 2.7 days. Currently, 6.7% of the company's shares are sold short.April 8, 2024 | markets.businessinsider.comNRx Pharma Achieves Data-lock In Phase 2b/3 Suicidal Treatment Resistant Bipolar Depression StudyApril 8, 2024 | prnewswire.comNRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar DepressionApril 3, 2024 | msn.comNew Brain Cap Lets People Play Video Games With Their MindsApril 3, 2024 | ca.news.yahoo.comRep. Raúl Grijalva announces cancer diagnosisApril 3, 2024 | ca.news.yahoo.comWoman, 23, diagnosed with cancer after thinking she was bloated with irritable bowel syndromeApril 2, 2024 | ca.news.yahoo.comAlberta creating 2 mental health and addictions organizations, including Crown corporationApril 2, 2024 | msn.comThere’s Nothing Wrong With Having Hooded EyesApril 2, 2024 | msn.comA dietitian explains how a 'diet break' can make it easier to lose weight and keep it offApril 2, 2024 | finance.yahoo.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2023 Earnings Call TranscriptApril 2, 2024 | marketbeat.comTrading was temporarily halted for "NRXP" at 07:04 PM with a stated reason of "News pending."April 1, 2024 | msn.comNRx Pharmaceuticals reports Q4 resultsApril 1, 2024 | prnewswire.comNRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 28, 2024 | finanznachrichten.deNRx Pharmaceuticals, Inc.: NRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq ListingMarch 28, 2024 | finance.yahoo.comNRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End HighlightsMarch 28, 2024 | prnewswire.comNRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq ListingMarch 27, 2024 | msn.comNRx Pharmaceuticals Set to Unveil Fourth Quarter and Full Year 2023 Financial ResultsMarch 27, 2024 | finance.yahoo.comUPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024March 25, 2024 | finance.yahoo.comNRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan Javitt to Present at the Ketamine 2024 Conference in Oxford, UKMarch 22, 2024 | finanznachrichten.deNRx Pharmaceuticals, Inc.: NRx Pharmaceuticals Announces Results of the Vote Held During the Special Meeting of ShareholdersMarch 22, 2024 | marketbeat.comNRx Pharmaceuticals (NRXP) Set to Announce Quarterly Earnings on ThursdayNRx Pharmaceuticals (NASDAQ:NRXP) will be releasing earnings after the market closes on Thursday, March 28, Zacks reports.March 21, 2024 | msn.comNRx Pharmaceuticals Forges Key Alliances to Bolster Ketamine Supply for Mental Health TreatmentMarch 21, 2024 | prnewswire.comNRx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 28, 2024March 21, 2024 | prnewswire.comNRx Pharmaceuticals Announces Results of the Vote Held During the Special Meeting of ShareholdersMarch 18, 2024 | msn.comNRx Pharma to distribute HOPE Therapeutics stock, pay Ketamine royalty to holders Get NRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Bible Shocker: Have You Seen Elon Musk’s Miracle? (Ad)Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process. Click here for the full story… NRXP Media Mentions By Week NRXP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NRXP News Sentiment▼0.200.42▲Average Medical News Sentiment NRXP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NRXP Articles This Week▼92▲NRXP Articles Average Week Get NRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BriaCell Therapeutics News Fortress Biotech News Spruce Biosciences News Acurx Pharmaceuticals News Aprea Therapeutics News Apollomics News Daré Bioscience News ImmunoPrecise Antibodies News Viracta Therapeutics News Marker Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NRXP) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressMan who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.”InvestorPlaceCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHow Biden has already won 2024Porter & CompanyUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
